Drug Profile
WHIP 131
Alternative Names: DDE 9501; WHI P131Latest Information Update: 10 Sep 2003
Price :
$50
*
At a glance
- Originator Wayne Hughes Institute
- Class Anti-inflammatories
- Mechanism of Action Apoptosis stimulants; Collagen inhibitors; Janus kinase 3 inhibitors; Mast cell inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic asthma; Amyotrophic lateral sclerosis; Cancer; Graft-versus-host disease; Skin disorders; Thromboembolism; Thrombosis
Most Recent Events
- 17 Sep 2001 Preclinical development for Graft-versus-host disease in USA (Unknown route)
- 05 Apr 2001 Preclinical development for Thromboembolism in USA (Unknown route)
- 05 Apr 2001 Preclinical development for Thrombosis in USA (Unknown route)